Introduction
Malaria is a significant global infectious disease, resulting in the deaths of 0.8-1.2 million people annually, and predominantly affects children under five years of age. 1 Despite recent preliminary data on a partially effective pre-erythrocytic stage vaccine (RTS, S), 2 malaria prevention and treatment presently relies on vector control and small molecule drugs. It is forseen that even if the RTS, S vaccine is approved for clinical use, it will be implemented as part of a multi-pronged approach that will also include antimalarial drugs in order to eradicate the parasite.
Whilst a number of drugs and drug combinations are used therapeutically to treat malaria, all have now succumbed to parasite drug resistance and/or reduced efficacy. 3 This, together with the fact that only five of the ~1,700 new drugs registered over the last 30 years were antimalarials, 4 highlights the need for the discovery and development of new antimalarial therapeutics.
Historically, natural products have played a significant role in the development of antimalarial drugs. [5] [6] [7] Notable examples include artemisinin from the Chinese medicinal plant
Artemisia annua, and quinine, which was isolated from the bark of the South American tree Cinchona succirubra. [5] [6] [7] This research has subsequently led to the development of numerous antimalarial drugs based on these two important plant natural products. 7 As part of our continuing research into the discovery of new antimalarial leads from nature [8] [9] [10] [11] [12] we screened a unique prefractionated fungi-derived library (2,035 fractions) against a chloroquine-sensitive Plasmodium falciparum line (3D7), using a radiometric growth inhibition assay. A total of 20 fractions derived from 18 fungal species (10 genera, 8 families) showed promising antimalarial activity; this equated to a screening hitrate of 0.98%. UV spectrum analysis of one antimalarial fraction derived from a Cortinarius species identified λ max values of 230 and 305 nm that were predicted to correspond to the compound(s) responsible for the observed antiparasitic activity. Large-scale UV-guided fractionation of the CH 2 Cl 2 /MeOH extract from this fungus resulted in the isolation of four known compounds: (1S,3R)-austrocortirubin (1), 13 (1S,3S)-austrocortirubin (2), 14 ,15 1-deoxyaustrocortirubin (3), 14, 15 and austrocortinin (4) 16 ( Figure 1 ).
Compound 2 was identified as a natural product scaffold that could be used in the generation of a tetrahydroanthraquinone-based compound library. Parallel solution-phase synthesis utilising scaffold 2 with 11 primary amines afforded a small library of N-substituted tetrahydroanthraquinones (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Herein we report the design and synthesis of 5-15, along with the in vitro antimalarial activity and mammalian cell toxicity for both the natural products (1) (2) (3) (4) and semi-synthetic analogues (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
Figure 1. Chemical structures for (1S,3R)-austrocortirubin (1), (1S,3S)-austrocortirubin (2), 1-deoxyaustrocortirubin (3) and austrocortinin (4).

Results and discussion
The air-dried and ground sample of Cortinarius sp. was sequentially extracted with CH 2 Cl 2 and MeOH. The combined CH 2 Cl 2 /MeOH extract was subjected to UV-guided fractionation using semi-preparative C 18 HPLC. This yielded the previously isolated tetrahydroanthraquinones, (1S,3R)-austrocortirubin (1), 13 (1S,3S)-austrocortirubin (2), 14, 15 and 1-deoxyaustrocortirubin (3). 14,15 A late eluting fraction from the HPLC fractionation was further purified by gel permeation chromatography to afford the known fungal anthraquinone, austrocortinin (4). 16 All compounds were identified on the basis of spectroscopic and spectrometric data and in comparison with literature values.
The polyketide-derived natural products 1-4 were originally isolated from the Australian toadstool, Dermocybe splendida, by Gill and co-workers and had their structures tentatively assigned on chemical and spectroscopic grounds, and were subsequently confirmed by single
crystal X-ray analyses on several semi-synthetic derivatives. [13] [14] [15] [16] The tetrahydroanthraquinone class has been identified as possessing moderate activity towards a variety of bacteria and fungi. 14 (Table 1) .
Inspired by literature reports of high-yielding N-alkylations of quinone motifs, such as those present in 1-3, we decided to exploit this chemistry for tetrahydroanthraquinone analogue generation and potential structure activity relationship (SAR) studies. [18] [19] [20] [21] This additional research had the potential to lead to compounds with increased potency, better selectivity and/or an increased stability toward biogenic nucleophiles. [18] [19] [20] [21] (1S,3S)-Austrocortirubin (2) was chosen for the semisynthetic studies since this molecule displayed the best in vitro antimalarial activity (with a similar selectivity to 1 and 3), and was available in suitable quantities (>50 mg) for library generation due to its moderate yield from the toadstool source. 8, 22, 23 Furthermore, the low MW (320), favourable cLog P (0.82), and multiple stereogenic centres (2) made 2 a suitable natural product scaffold for library synthesis (Table 1) . [24] [25] [26] [27] 6
The concept of isolating a natural product scaffold for lead optimisation studies or screening library generation has previously been reported in the literature, although relatively few examples exist. 28 The purification and subsequent use of tambjamine, 22 In order to obtain larger quantities of (1S,3S)-austrocortirubin for our semi-synthetic studies additional large-scale extraction and isolation work was conducted on the air-dried and ground
Cortinarius material, which yielded 91 mg of 2.
Prior to semi-synthetic studies commencing on scaffold 2, a virtual library was constructed using a list of commercially available primary amines (30 in total) 31 and Instant JChem software 32 and the data compared to Lipinski's drug-like "Rule of Five" 27 (MW < 500; HBA < 10; HBD < 5;
Log P < 5) criteria. The physicochemical parameter profiles (MW, HBA, HBD, Log P) for all virtual molecules were analysed in an effort to select the most desirable drug-like molecules for subsequent synthesis. On the basis of the in silico data (Table 1) following interpretation of the gCOSY, gHSQC and gHMBC data. The N-alkylation of the tetrahydroanthraquinone core was deemed to have taken place at C-6, on the basis of a literature report on the related mono-methoxylated quinone, fredericamycin A. 21 Semi-synthetic studies on this Streptomyces-derived natural product had shown that the methoxy group was readily replaced by nucleophiles such as primary amines. 21 Confirmaton of the N-alkylation position for 5 was also 34 which also displayed large specific rotations.
Furthermore, compounds 5-15, awamycin and rubradirin are all red, and have UV chromophores that typically extend past 500 nm. 33, 34 We postulate that the UV absorption characteristics of these molecules may be the cause for the large specific rotations. Compounds 5-15 were all tested for in vitro growth inhibitory activity against P.
falciparum 3D7 parasites and mammalian cell toxicity using the NFF cell line ( Table 1 ). Eight of the 11 semi-synthetic analogues (5, 6, 9-11, 13-15) displayed IC 50 values < 7.4 M against the malaria parasite that were comparable to the natural products 1-3. While none of the synthons displayed improved potency compared to 2, compounds 6 and 11 showed 2.2-and 1.9-fold better selectivity. The lack of SAR for analogues 5-15 indicates that ring A plays a more important role for bioactivity than ring C ( Figure 1 ) and thus any future medicinal chemistry on this unique tetrahydroanthraquinone core should focus on generating analogues that would probe ring A for SAR. (21), which is typically co-administered with proguanil in the treatment of P. falciparum infections. The mechanism of action for atovaquone has been determined and involves the inhibition of the cytochrome bc1 complex in Plasmodium parasites. [39] [40] [41] On the basis of this data it has been hypothesized that many of the previously reported quinonebased antimalarial natural products may also interfere with the mitochondrial electron transport system in the malaria parasite.
42-44
Figure 4. Quinone-based antimalarial compounds.
Conclusion
In summary, UV-guided fractionation on the bioactive CH 2 Cl 2 /MeOH extract from the was Millipore Milli-Q PF filtered. All amine reagents were purchased from Sigma-Aldrich.
Fungal material
The toadstool Cortinarius sp. 
Extraction and isolation
The air-dried and ground fruit-bodies of Cortinarius sp. (10 g) were transferred to a conical flask (1 L) and extracted with CH 2 Cl 2 (250 mL), the mixture was shaken at 200 rpm for 2 h. The resulting extract was filtered under gravity, and set aside. MeOH (250 mL) was added to the fungal sample, and the flask shaken at 200 rpm for 2 h before filtration. 
(1S,3R)-Austrocortirubin
Austrocortinin (4)
Orange amorphous solid; NMR and MS were consistent with literature values. 
Antimalarial assays
P. falciparum growth inhibition assays were carried out using an isotopic microtest, as previously described. 45 Briefly, ring-stage P. falciparum infected erythrocytes (0.5% parasitemia and 2.5% hematocrit) were seeded into 96 well tissue culture plates containing serial dilutions of control (chloroquine) or test compounds. Following 48 h incubation under standard P. falciparum culture conditions, 0.5 µCi 3 H-hypoxanthine was added to each well after which the plates were cultured for a further 24 h. Cells were harvested onto 1450 MicroBeta filter mats (Wallac) and 3 H incorporation was determined using a 1450 MicroBeta liquid scintillation counter. P. falciparum growth inhibition was compared to DMSO controls (0.5%), and IC 50 values were calculated using linear interpolation of inhibition curves. 45 The mean IC 50 (± SD) is shown for three independent experiments, each carried out in triplicate. 46 Inc., Rockville, MD) supplemented with 10% FCS (CSL Biosciences, Parkville, Victoria, Australia), 1% streptomycin (Life Technologies, Inc., Rockville, MD; complete medium) at 37 °C and 5% CO 2 . Cells were maintained in log phase growth and seeded (3,000/well) into 96-well tissue culture plates (Corning, USA) then cultivated for 24 h before treatment. Compounds were dissolved in DMSO and diluted in complete medium; the DMSO concentration in the medium did not exceed 1%. Control cells were treated with the equivalent dose of DMSO. Three days after treatment initiation, the cells were washed with PBS and fixed in methylated spirits, total protein was determined using sulforhodamine B as described previously. 46 Compounds were tested in triplicate in three independent experiments.
Cytotoxicity assay
